CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The new online Learning Center with new content can still be found under the “Training” folder on ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...